This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Yannick Fillon, PhD
Head of Oligonucleotide Process Chemistry at Biogen
Speaker

Profile

Yannick Fillon obtained his chemical engineering degree in France in 2001 (ESCPE, Lyon) and PhD in Organic Chemistry in Purdue University in 2006. He started his career at Sigma-Aldrich (now Millipore Sigma) in Houston Texas with the Custom Product division where he focused his efforts on the process development and improvement for the production of peptides and oligonucleotides.

In 2012 he moved to Boston to work for Cubist Pharmaceuticals, but subsequently joined the budding Antisense Oligonucleotide group at Biogen in 2014 as a Senior Scientist. He is currently the Head of Oligonucleotide Process Chemistry where his group focuses on the development of oligonucleotide drug candidates with solid and liquid phase synthesis.

Agenda Sessions

  • Scaling Up Solution Phase Oligo Manufacturing and Future Innovations

    08:05
  • Process Development & Manufacturing of Oligos

    11:15